KIMBERLY ALLEN: Open Payments
NPI 1932340478 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 23 payments from 13 companies in 2025. Trend: 2023 $275 · 2024 $92 · 2025 $530
Food & beverage: $530
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $168 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $82 |
| Novo Nordisk Inc | 2 | $41 |
| Intra-Sana Laboratories | 2 | $38 |
| Corcept Therapeutics | 2 | $37 |
| SHIELD THERAPEUTICS INC | 1 | $30 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Kowa Pharmaceuticals America, Inc. | 1 | $23 |
| IBSA Pharma Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $18 |
Products named: VRAYLAR, TRINTELLIX, Wegovy, RELTONE 200 MG, Korlym, ACCRUFER, UBRELVY, Symbravo.
Industry payments across OK — which companies pay providers there.
